Observational Study Evaluating the Body Weight Progress During the Treatment With Insulin Detemir (Levemir) in Type 2 Patients, Previously Treated With Other Basal Insulins.
Phase of Trial: Phase IV
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 13 Jan 2010 Planned number of patients changed from 200 to 206 as reported by ClinicalTrials.gov.
- 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.